Loading...
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial
BACKGROUND: Although reperfusion injury has been shown to be responsible for cardiomyocytes death after an acute myocardial infarction, there is currently no drug on the market that reduces this type of injury. TRO40303 is a new cardioprotective compound that was shown to inhibit the opening of the...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3923730/ https://ncbi.nlm.nih.gov/pubmed/24507657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-38 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|